Who owns TENAX THERAPEUTICS INC?
- Ticker: TENX
- CUSIP Number: 88032l605
Tip: Access positions for across all investors
Analyze quarterly positions in Tenax Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Tenax Therapeutics stock
Who bought or sold TENAX THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 340k | $1.2M | 100% | Sep 2024 |
|
VR Adviser | 208k | $721k | 100% | Sep 2024 |
|
Vestal Point Capital | 83k | $288k | 100% | Sep 2024 |
|
Stonepine Capital Management | 50k | $173k | 100% | Sep 2024 |
|
T. Rowe Price Associates | 24k | $84k | 100% | Sep 2024 |
|
Dimensional Fund Advisors | 21k | $73k | 100% | Sep 2024 |
|
Geode Capital Management | 18k | $64k | 67% | Sep 2024 |
|
Lynx1 Capital Management | 15k | $51k | 100% | Sep 2024 |
|
Qube Research & Technologies | 4.4k | $13k | 0% | Jun 2024 |
|
Tower Research Capital | 961.00 | $2.9k | 79% | Jun 2024 |
|
BlackRock | 300.00 | $1.0k | 100% | Sep 2024 |
|
BlackRock | 300.00 | $903.990000 | 0% | Jun 2024 |
|
Morgan Stanley | 260.00 | $784.004000 | 0% | Jun 2024 |
|
Bank of America Corporation | 28.00 | $97.000400 | 75% | Sep 2024 |
|
Hanson McClain Advisors | 1.00 | $4.000000 | 0% | Sep 2024 |
|
Who sold out of Tenax Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Atlantic Trust | Jun 2024 | 343.00 | $1.1k |
Royal Bank of Canada | Jun 2024 | 1.00 | $0 |
Tucker Asset Management | Mar 2024 | 1.00 | $4.000000 |